The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Investigation of prognostic factors for second-line treatment with nivolumab for unresectable or recurrent esophageal cancer.
 
Takashi Ogata
Honoraria - Bristol-Myers Squibb; Ono Yakuhin
 
Nozomu Machida
No Relationships to Disclose
 
Kosuke Takahashi
No Relationships to Disclose
 
Kazuki Kano
No Relationships to Disclose
 
Keisuke Koumori
No Relationships to Disclose
 
Hayato Watanabe
No Relationships to Disclose
 
Hirohito Fujikawa
No Relationships to Disclose
 
Takanobu Yamada
Honoraria - Johnson & Johnson/Janssen; Nihonkayaku; Taiho Pharmaceutical
 
Yasuhiro Inokuchi
No Relationships to Disclose
 
Mitsuhiro Furuta
No Relationships to Disclose
 
Yoshihiro Kaneta
No Relationships to Disclose
 
Kei Hayashi
No Relationships to Disclose
 
Ayaka Ishida
No Relationships to Disclose
 
Takashi Oshima
No Relationships to Disclose